
Dual GIP/GLP-1 receptor agonist for metabolic studies
Purchase Options
Vial Size
Quantity
| Single vial | Kit (10 vials) | Bulk (30 vials) | |
|---|---|---|---|
| 5mg | ₪200 | ₪1,600 | ₪4,200 |
| 10mg | ₪370 | ₪2,960 | ₪7,770 |
| 20mg | ₪680 | ₪5,440 | ₪14,280 |
Kit saves 20% vs single. Bulk (30+ vials) saves 30%. Prices confirmed on inquiry.
Message us for bulk pricing →Number of Units
For laboratory research purposes only. Not for human consumption.
| Property | Value |
|---|---|
| Molecular Weight | 4813.5 g/mol |
| Half-Life | 5 days |
| Storage | -20°C lyophilized, 2-8°C reconstituted |
| Purity | ≥98% HPLC |
| CAS Number | 2023788-19-2 |
| Form | Lyophilized powder |
Tirzepatide is a synthetic peptide that functions as a dual agonist, activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism makes it a unique research compound in metabolic studies. Researchers investigate its effects on glucose homeostasis, insulin secretion, and energy metabolism in laboratory settings.
Scientists study Tirzepatide for its potential effects on metabolic pathways, particularly its dual receptor activation mechanism. Research focuses on how GIP and GLP-1 receptor stimulation influences insulin sensitivity, glucagon suppression, gastric emptying, and appetite regulation. Studies examine its impact on body composition, lipid metabolism, and cellular energy utilization in various research models.
Prepare bacteriostatic water (or sterile water for immediate use), insulin syringe, and alcohol swabs.
Wipe the rubber stopper of the peptide vial with an alcohol swab and allow to dry for 30 seconds.
Draw the desired volume of bacteriostatic water into the syringe. Inject slowly down the side of the vial — never directly onto the powder.
Swirl gently or roll between palms. Never shake vigorously as this can damage the peptide structure and reduce potency.
Solution should be clear with no visible particles. If cloudiness persists, allow more time to dissolve before use.
Store reconstituted solution at 2-8°C (refrigerator). Use within 14-28 days depending on solvent used.
For detailed protocols, see our Peptide Research Guides.
All our research compounds are HPLC-verified with ≥98% purity. Certificates of Analysis from our certified testing laboratories are available upon request. Each COA includes purity percentage, mass spectrometry data, and batch information.
Jastreboff AM et al. "Tirzepatide Once Weekly for the Treatment of Obesity." N Engl J Med. 2022.
Frias JP et al. "Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes." N Engl J Med. 2021.
Rosenstock J et al. "Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide." Lancet. 2021.
References provided for educational purposes. All compounds are for laboratory research use only.
Contact us for pricing, availability, and bulk orders.
Pricing (ILS)
HPLC-verified purity documentation available for every batch.
All compounds supplied strictly for laboratory research. Not for human consumption.
Contact us via WhatsApp or Telegram for pricing, availability, bulk orders, and COA requests. Fast response guaranteed.